June 1, 2016 | Net Health
3 Minute Read
The Strategic View of Modified Stage 2 Meaningful Use: Part 6
As in previous columns, we are continuing to review the objectives and measures for Modified Stage 2 Meaningful Use (MU) set forth from 2015 through 2017. In this column, you will find information detailing Objective 10: Public Health Reporting Measure Option 2—Syndromic Surveillance Reporting.
The Centers for Medicare & Medicaid Services (CMS) provided a definition of syndromic surveillance (FAQ 3615)1 reporting as “Syndromic surveillance uses individual and population health indicators that are available before confirmed diagnoses or laboratory confirmation to identify outbreaks or health events and monitor the health status of a community.” The CMS refers to the Centers for Disease Control and Prevention (CDC) for further explanation of syndromic surveillance2:
“Public health syndromic surveillance using inpatient and ambulatory clinical care electronic health record (EHR) data is a relatively new practice. As eligible health professionals and hospitals adopt, implement, and upgrade their EHR systems through the CMS EHR Incentive Programs (MU programs), there is an opportunity for public health agencies to routinely receive health data from settings other than emergency departments and urgent care centers…
See the reference table and read the rest of this article in Advances in Skin & Wound Care.
An excerpt from an article originally published in Advances in Skin & Wound Care, written by Cathy Thomas Hess, BSN, RN, CWCN, VP and Chief Clinical Officer for Wound Care at Net Health.
